We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
Cap. Flow
+$73M
Cap. Flow %
1.04%
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$182M
2
ENDP
Endo International plc
ENDP
+$170M
3
AET
Aetna Inc
AET
+$131M
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$108M
5
BKD icon
Brookdale Senior Living
BKD
+$91.4M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$435M
2
ELV icon
Elevance Health
ELV
+$121M
3
CI icon
Cigna
CI
+$119M
4
WMGI
Wright Medical Group Inc
WMGI
+$82.7M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.8M

Sector Composition

Rank Sector Weight
1 Healthcare 49.34%
2 Financials 7.86%
3 Consumer Discretionary 7.17%
4 Technology 6.32%
5 Industrials 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAL icon
1076
PUT
Halliburton
HAL
$26.9B
$22K ﹤0.01%
1,067
+74
+7% +$3.41K
SPLS
1077
CALL
DELISTED
Staples Inc
SPLS
$21K ﹤0.01%
+250
New +$4.07K
CTRX
1078
CALL
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$17K ﹤0.01%
+3,321
New +$199K
SPNC
1079
CALL
DELISTED
Spectranetics Corp
SPNC
$16K ﹤0.01%
+500
New +$14K
IMAX icon
1080
CALL
IMAX
IMAX
$2.62B
$14K ﹤0.01%
+1,000
New +$38.8K
EIGR
1081
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$13K ﹤0.01%
23
-5
-18% -$13.8K
PTCT icon
1082
PUT
PTC Therapeutics
PTCT
$5.68B
$12K ﹤0.01%
+252
New +$14.7K
TWC
1083
PUT
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$12K ﹤0.01%
643
-1,190
-65% -$197K
T icon
1084
PUT
AT&T
T
$159B
$11K ﹤0.01%
+216
New +$5.58K
ABBV icon
1085
PUT
AbbVie
ABBV
$443B
$8K ﹤0.01%
+429
New +$28K
CCJ icon
1086
CALL
Cameco
CCJ
$37.6B
$8K ﹤0.01%
2,875
+75
+3% +$1.18K
ZBH icon
1087
CALL
Zimmer Biomet
ZBH
$18.2B
$8K ﹤0.01%
+258
New +$28.5K
HERO
1088
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
$7K ﹤0.01%
30,566
+18,066
+145% +$12.3K
CYHHZ
1089
CALL
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$5K ﹤0.01%
+276,596
New +$5.2K
DRC
1090
PUT
DELISTED
DRESSER-RAND GROUP INC
DRC
$5K ﹤0.01%
864
+65
+8% +$5.44K
DGX icon
1091
CALL
Quest Diagnostics
DGX
$25.7B
$3K ﹤0.01%
+200
New +$14.8K
CAH icon
1092
CALL
Cardinal Health
CAH
$53.9B
$1K ﹤0.01%
+300
New +$26.5K
ABEV icon
1093
Ambev
ABEV
$48.1B
– –
-81,605
Closed -$470K
ABUS icon
1094
Arbutus Biopharma
ABUS
$857M
– –
-30,000
Closed -$524K
ACGL icon
1095
Arch Capital
ACGL
$34.3B
– –
-874,326
Closed -$18M
ACN icon
1096
Accenture
ACN
$102B
– –
-4,400
Closed -$412K
ADBE icon
1097
Adobe
ADBE
$99.5B
– –
-10,600
Closed -$784K
ADEA icon
1098
Adeia
ADEA
$2.94B
– –
-211,385
Closed -$2.25M
ADTN icon
1099
Adtran
ADTN
$689M
– –
-16,362
Closed -$305K
AFL icon
1100
Aflac
AFL
$64.9B
– –
-9,050
Closed -$290K
42 43
44
45 46

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
  • Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
  • Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
  • Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
  • Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
  • Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
  • Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.

Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.